Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Alessandro D. Genazzani, Christian Battipaglia, Tabatha Petrillo, Nicola Piacquadio, Fedora Ambrosetti, Melania Arnesano, Elisa Semprini, Alessandra Sponzilli, Veronica Tomatis & Tommaso Simoncini. (2022) Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index. Gynecological Endocrinology 38:8, pages 681-688.
Read now
Read now
Oliver C. Watkins, Hannah E. J. Yong, Neha Sharma & Shiao-Yng Chan. (2022) A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. Critical Reviews in Food Science and Nutrition 62:6, pages 1626-1673.
Read now
Read now
Luigi Della Corte, Virginia Foreste, Fabio Barra, Claudio Gustavino, Franco Alessandri, Maria Grazia Centurioni, Simone Ferrero, Giuseppe Bifulco & Pierluigi Giampaolino. (2020) Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opinion on Investigational Drugs 29:8, pages 819-830.
Read now
Read now
Franca Fruzzetti, Tiziana Fidecicchi, Giulia Palla & Marco Gambacciani. (2020) Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. Gynecological Endocrinology 36:2, pages 152-155.
Read now
Read now
Tomasz Szkudelski, Iwona Hertig & Katarzyna Szkudelska. (2018) Lack of effects of myo-inositol on metabolism of primary rat adipocytes. Archives of Physiology and Biochemistry 124:4, pages 344-350.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
Cuma Mertoglu, Murat Gunay, Vahdet Gul, Mehmet Kulhan, Mehmet Aktas & Taha Abdulkadir Coban. (2018) Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?. Gynecological Endocrinology 34:5, pages 418-421.
Read now
Read now
Dinka Pavicic Baldani, Lana Skrgatic, Roya Ougouag & Miro Kasum. (2018) The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment. Gynecological Endocrinology 34:2, pages 87-91.
Read now
Read now
E. V. Vartanyan, K. A. Tsaturova, E. A. Devyatova, A. S. Mikhaylyukova, V. A. Levin, N. L. Petuhova, A. V. Markin & E. M. Steptsova. (2017) Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization. Gynecological Endocrinology 33:sup1, pages 8-11.
Read now
Read now
Rosario D’Anna, Angelo Santamaria, Grazia Giorgianni, Alberto Vaiarelli, Giuseppe Gullo, Flavia Di Bari & Salvatore Benvenga. (2017) Myo-inositol and melatonin in the menopausal transition. Gynecological Endocrinology 33:4, pages 279-282.
Read now
Read now
Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri. (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecological Endocrinology 33:1, pages 1-9.
Read now
Read now
Vittorio Unfer, Beatrice Orrù & Giovanni Monastra. (2016) Inositols: from physiology to rational therapy in gynecological clinical practice. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1129-1131.
Read now
Read now
Ewa M. Milewska, Adam Czyzyk, Blazej Meczekalski & Alessandro D. Genazzani. (2016) Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology 32:9, pages 690-695.
Read now
Read now
Cristiana Paul, Antonio Simone Laganà, Paolo Maniglio, Onofrio Triolo & David M. Brady. (2016) Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 32:6, pages 431-438.
Read now
Read now
Morena Luigia Rocca, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Angela Sacchinelli, Valentina Russo, Simona Trapasso, Fulvio Zullo & Michele Morelli. (2015) Polycystic ovary syndrome: chemical pharmacotherapy. Expert Opinion on Pharmacotherapy 16:9, pages 1369-1393.
Read now
Read now
Vittorio Unfer & Giuseppina Porcaro. (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology 7:5, pages 623-631.
Read now
Read now
Alessandro D. Genazzani, Susanna Santagni, Erika Rattighieri, Elisa Chierchia, Giulia Despini, Giulia Marini, Alessia Prati & Tommaso Simoncini. (2014) Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecological Endocrinology 30:6, pages 438-443.
Read now
Read now
Articles from other publishers (99)
Alice Guarano, Anna Capozzi, Martina Cristodoro, Nicoletta Di Simone & Stefano Lello. (2023) Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?. Nutrients 15:14, pages 3209.
Crossref
Crossref
Pradipkumar Vaghela, Khanjan Trivedi, K.G. Vijay Anand, Jibananand Nayak, Divya Vyas & Arup Ghosh. (2023) Aqueous homogenate of fresh Ulva lactuca for ameliorating nutrient deficiency—A nutraceutical alternative to using whole seaweeds. Algal Research 74, pages 103211.
Crossref
Crossref
Pranali Y. Umredkar, Vijay M. Tangde, Niraj T. Khaty, Kapil S. Ganorkar & Sudhakar S. Dhondge. (2023) Effect of aqueous solutions of KCl, MgCl2, Dextrose and Urea on solvation behavior of aqueous myo-Inositol. Journal of Molecular Liquids 377, pages 121522.
Crossref
Crossref
Mariano Bizzarri, Noemi Monti, Aurora Piombarolo, Antonio Angeloni & Roberto Verna. (2023) Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. Nutrients 15:8, pages 1875.
Crossref
Crossref
Valeria Fedeli, Angela Catizone, Alessandro Querqui, Vittorio Unfer & Mariano Bizzarri. (2023) The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results. International Journal of Molecular Sciences 24:7, pages 6296.
Crossref
Crossref
Su Min Lim, Dong Seong Choi, Mi‐Nam Chung, Jae‐Sun Lee, Young‐Sik Kang, Kyu‐Hwan Choi, Jin‐Young Moon, Sang‐Sik Nam & Mun Yhung Jung. (2023)
High impacts of cultivar and home‐cooking practice on the content of free
myo
‐inositol, a bioavailable health‐promoting cyclitol, in sweet potato
. Journal of Food Science 88:2, pages 772-783.
Crossref
Crossref
Khetan Shevkani. 2023. Future Proteins. Future Proteins
35
68
.
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Antonio Simone Laganà, Cesare Aragona & Nikos Prapas. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
175
195
.
John A. BarryJohn A. Barry. 2023. Psychologische Aspekte des polyzystischen Ovarial-Syndroms (PCOS). Psychologische Aspekte des polyzystischen Ovarial-Syndroms (PCOS)
139
159
.
Anaa Makhdoomi, Naila Jan, Palak Palak & Nidhi Goel. (2022) Machine learning techniques for medical images in PCOS. Machine learning techniques for medical images in PCOS.
Tabatha Petrillo, Elisa Semprini, Veronica Tomatis, Melania Arnesano, Fedora Ambrosetti, Christian Battipaglia, Alessandra Sponzilli, Francesco Ricciardiello, Andrea R. Genazzani & Alessandro D. Genazzani. (2022) Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients. Biomedicines 10:8, pages 1924.
Crossref
Crossref
Hardik Jethaliya, Nirva Gajjar, Vrushank Patel, Shrikalp Deshpande & Roshni Patel. (2022) Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. Reproductive Sciences 29:8, pages 2282-2298.
Crossref
Crossref
Ling-Hui Zeng, Saba Rana, Liaqat Hussain, Muhammad Asif, Malik Hassan Mehmood, Imran Imran, Anam Younas, Amina Mahdy, Fakhria A. Al-Joufi & Shaymaa Najm Abed. (2022) Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies. Frontiers in Pharmacology 13.
Crossref
Crossref
James J DiNicolantonio & James H O'Keefe. (2022) Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart 9:1, pages e001989.
Crossref
Crossref
Franz Geisthövel, Birgit Wetzka & Aida Hanjalic-Beck. 2020. Die Gynäkologie. Die Gynäkologie
1
33
.
Konstantinos AnastassakisKonstantinos Anastassakis. 2022. Androgenetic Alopecia From A to Z. Androgenetic Alopecia From A to Z
343
345
.
Paolo Giovanni Artini, Elisa Malacarne & Vito Cela. (2021) PCOS and Assisted Reproduction Technique: Role and Relevance of Inositols. Endocrines 2:4, pages 515-522.
Crossref
Crossref
Sahar Mohammadi, Fatemeh Eini, Fatemeh Bazarganipour, Seyed Abdolvahab Taghavi & Maryam Azizi Kutenaee. (2021) The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial. Reproductive Biology and Endocrinology 19:1.
Crossref
Crossref
Khara Lucius. (2021) Diet, Nutritional Supplements, and Botanical Medicine in Polycystic Ovary Syndrome. Alternative and Complementary Therapies 27:6, pages 289-297.
Crossref
Crossref
Che-Chia Hsu, Xian Zhang, Guihua Wang, Weina Zhang, Zhen Cai, Bo-Syong Pan, Haiwei Gu, Chuan Xu, Guoxiang Jin, Xiangshang Xu, Rajesh Kumar Manne, Yan Jin, Wei Yan, Jingwei Shao, Tingjin Chen, Emily Lin, Amit Ketkar, Robert Eoff, Zhi-Gang Xu, Zhong-Zhu Chen, Hong-Yu Li & Hui-Kuan Lin. (2021) Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK. Molecular Cell 81:18, pages 3803-3819.e7.
Crossref
Crossref
Michele Russo, Gianpiero Forte, Mario Montanino Oliva, Antonio Simone Laganà & Vittorio Unfer. (2021) Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth. International Journal of Molecular Sciences 22:16, pages 8433.
Crossref
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Crossref
Kate Davies. (2020) Biological basis of child health 7: growth, development and the reproductive system. Nursing Children and Young People 33:2, pages 33-43.
Crossref
Crossref
Е.В. Новикова. (2021) Pregravid Preparation – What’s New?. Репродуктивное здоровье. Восточная Европа:6, pages 737-741.
Crossref
Crossref
Jun Xu, Guning Liu, Sheila M. Hegde, Priya Palta, Eric Boerwinkle, Kelley P. Gabriel & Bing Yu. (2021) Physical Activity-Related Metabolites Are Associated with Mortality: Findings from the Atherosclerosis Risk in Communities (ARIC) Study. Metabolites 11:1, pages 59.
Crossref
Crossref
Alessia Prati, Andrea R. Genazzani & Alessandro D. Genazzani. 2021. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health
43
66
.
George Asimakopoulos, Vasilios Pergialiotis, Eleni Anastasiou, Panagiotis Antsaklis, Mariana Theodora, Evangelia Vogiatzi, Aggela Kallergi, Michael Sindos, Dimitrios Loutradis & George Daskalakis. (2020) Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. Trials 21:1.
Crossref
Crossref
Karol Wiśniewski, Marcin Jozwik & Joanna Wojtkiewicz. (2020) Cancer Prevention by Natural Products Introduced into the Diet—Selected Cyclitols. International Journal of Molecular Sciences 21:23, pages 8988.
Crossref
Crossref
Vittorio Unfer, Simona Dinicola, Antonio Simone Laganà & Mariano Bizzarri. (2020) Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. International Journal of Molecular Sciences 21:19, pages 7157.
Crossref
Crossref
Г. О. Ісламова. (2020) Pregravid preparation of women with polycystic ovary syndrome.. REPRODUCTIVE ENDOCRINOLOGY:53, pages 30-34.
Crossref
Crossref
Elizabeth Greene, Barbara Mallmann, Jonathan W. Wilson, Aaron J. Cowieson & Sami Dridi. (2020) Monitoring Phytate Hydrolysis Using Serial Blood Sampling and Feather Myo-Inositol Levels in Broilers. Frontiers in Physiology 11.
Crossref
Crossref
Arianna Pani, Ilaria Gironi, Giacoma Di Vieste, Elena Mion, Federico Bertuzzi & Basilio Pintaudi. (2020) From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management. International Journal of Endocrinology 2020, pages 1-10.
Crossref
Crossref
Anja Wüest. (2020) Prävention der metabolischen und kardiovaskulären Langzeitfolgen bei polyzystischem Ovarsyndrom (PCOS)Prévention des conséquences métaboliques et cardio-vasculaires à long terme du syndrome des ovaires polykystiques (SOPK). Journal für Gynäkologische Endokrinologie/Schweiz 23:2, pages 56-61.
Crossref
Crossref
M. Caputo, E. Bona, I. Leone, M.T. Samà, A. Nuzzo, A. Ferrero, G. Aimaretti, P. Marzullo & F. Prodam. (2020) Inositols and metabolic disorders: From farm to bedside. Journal of Traditional and Complementary Medicine 10:3, pages 252-259.
Crossref
Crossref
Franca Fruzzetti, Elena Benelli, Tiziana Fidecicchi & Massimo Tonacchera. (2020) Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome. International Journal of Endocrinology 2020, pages 1-8.
Crossref
Crossref
S. Tripathi, M. Singh, M. Jain & S. Khatoon. (2020) Nutritional perspective of polycystic ovarian syndrome: A review study. Current Medicine Research and Practice 10:2, pages 65-69.
Crossref
Crossref
D.V. Ovcharenko, A.A. Popov, A.A. Koval’, S.S. Tyurina & A.A. Fedorov. (2020) The effect of nutrients on metabolic disorders associated with polycystic ovary syndrome. Rossiiskii vestnik akushera-ginekologa 20:4, pages 27.
Crossref
Crossref
Angelika Sobota-Grzeszyk, Mariusz Kuźmicki & Jacek Szamatowicz. (2019) Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?. Journal of Diabetes Research 2019, pages 1-5.
Crossref
Crossref
І. А. Жабченко & О. Р. Сюдмак. (2019) Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods. Reproductive Endocrinology 0:49, pages 43-49.
Crossref
Crossref
Giuseppe Sferrazzo, Rosa Palmeri, Luca Vanella, Lucia Parafati, Simone Ronsisvalle, Antonio Biondi, Francesco Basile, Giovanni Li Volti & Ignazio Barbagallo. (2019) Mangifera indica L. Leaf Extract Induces Adiponectin and Regulates Adipogenesis. International Journal of Molecular Sciences 20:13, pages 3211.
Crossref
Crossref
Sociedad Española de Ginecología y Obstetricia SEGO. (2019) Estimulación ovárica para fecundación in vitro-inyección intracitoplasmática de espermatozoides en los ciclos con presunción de alta respuesta (2017). Progresos de Obstetricia y Ginecología.
Crossref
Crossref
John A. BarryJohn A. Barry. 2019. Psychological Aspects of Polycystic Ovary Syndrome. Psychological Aspects of Polycystic Ovary Syndrome
121
139
.
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson & Cindy Farquhar. (2018) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Mario Montanino Oliva, Giovanna Buonomo, Marco Calcagno & Vittorio Unfer. (2018) Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. Journal of Ovarian Research 11:1.
Crossref
Crossref
Reza Tabrizi, Vahidreza Ostadmohammadi, Kamran B. Lankarani, Payam Peymani, Maryam Akbari, Fariba Kolahdooz & Zatollah Asemi. (2018) The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Lipids in Health and Disease 17:1.
Crossref
Crossref
Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Massimo Franchi & Fabio Ghezzi. (2018) Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends in Endocrinology & Metabolism 29:11, pages 768-780.
Crossref
Crossref
Antonio Simone Laganà, Amerigo Vitagliano, Marco Noventa, Guido Ambrosini & Rosario D’Anna. (2018) Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics 298:4, pages 675-684.
Crossref
Crossref
Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine & Rene Druckman. (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation 34:2.
Crossref
Crossref
Costanzo Moretti & Giulia Lanzolla. (2018) Uso dell’inositolo nella sindrome dell’ovaio policistico. L'Endocrinologo 19:S1, pages 17-19.
Crossref
Crossref
J Pundir, D Psaroudakis, P Savnur, P Bhide, L Sabatini, H Teede, A Coomarasamy & S Thangaratinam. (2018) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology 125:3, pages 299-308.
Crossref
Crossref
Jun-Yeong Jeon, Seok-Young Kim, Hye-Youn Kim, So-Hyun Kim, Byeong-Ju Lee, Sa Rang Lim & Hyung-Kyoon Choi. (2018) Effects of Agitating Culture Condition on the Growth, Metabolic and Carotenoid Profiles of Lemna paucicostata. Biotechnology and Bioprocess Engineering 23:1, pages 23-30.
Crossref
Crossref
Xiulai Chen, Cong Gao, Liang Guo, Guipeng Hu, Qiuling Luo, Jia Liu, Jens Nielsen, Jian Chen & Liming Liu. (2017) DCEO Biotechnology: Tools To Design, Construct, Evaluate, and Optimize the Metabolic Pathway for Biosynthesis of Chemicals. Chemical Reviews 118:1, pages 4-72.
Crossref
Crossref
T. A. Nazarenko & K. M. Isakova. (2018) Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review). Problemy reproduktsii 24:4, pages 33.
Crossref
Crossref
Liuting Zeng & Kailin Yang. (2017) Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 59:1, pages 30-38.
Crossref
Crossref
John E. Nestler & Antonio Simone Laganà. 2018. Infertility in Women with Polycystic Ovary Syndrome. Infertility in Women with Polycystic Ovary Syndrome
213
226
.
Kendall C. Case, Michael Salsaa, Wenxi Yu & Miriam L. Greenberg. 2020. Lipid Signaling in Human Diseases. Lipid Signaling in Human Diseases
221
260
.
Kosei Tanaka, Ayane Natsume, Shu Ishikawa, Shinji Takenaka & Ken-ichi Yoshida. (2017) A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production. Microbial Cell Factories 16:1.
Crossref
Crossref
Xiangqin Zheng, Danmei Lin, Yulong Zhang, Yuan Lin, Jianrong Song, Suyu Li & Yan Sun. (2017) Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine 96:49, pages e8842.
Crossref
Crossref
Rafael Turra Alarcon, Caroline Gaglieri, Flávio Junior Caires, Aroldo Geraldo Magdalena, Ricardo António Esteves de Castro & Gilbert Bannach. (2017) Thermoanalytical study of sweetener myo-inositol: α and β polymorphs. Food Chemistry 237, pages 1149-1154.
Crossref
Crossref
C. Vincentelli, B. Gaborit, V. Castera, A. Dutour Meyer & B. Courbiere. (2017) Prise en charge de l’infertilité chez la femme obèseManagement of infertility in obese women. Obésité 12:3, pages 186-192.
Crossref
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Crossref
Valeria Tagliaferri, Daniela Romualdi, Valentina Immediata, Simona De Cicco, Christian Di Florio, Antonio Lanzone & Maurizio Guido. (2017)
Metformin
vs
myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study
. Clinical Endocrinology 86:5, pages 725-730.
Crossref
Crossref
Antonio Simone Laganà, Paola Rossetti, Fabrizio Sapia, Benito Chiofalo, Massimo Buscema, Gaetano Valenti, Agnese Maria Chiara Rapisarda & Salvatore Giovanni Vitale. (2017) Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease. International Journal of Endocrinology and Metabolism 15:1.
Crossref
Crossref
E. V. Vartanyan, K. A. Tsaturova, E. A. Devyatova, A. S. Mikhaylyukova, V. A. Levin, N. L. Petuhova, A. V. Markin & E. M. Steptsova. (2017) The reserves for improvement of quality of oocytes in polycystic ovarian syndrome. Problemy reproduktsii 23:3, pages 50.
Crossref
Crossref
Minisha Sood, Susan B. Zweig, Marsha C. Tolentino, Marina Strizhevsky & Leonid Poretsky. 2017. Principles of Diabetes Mellitus. Principles of Diabetes Mellitus
659
677
.
Alessandro D. Genazzani. (2016) Inositol as putative integrative treatment for PCOS. Reproductive BioMedicine Online 33:6, pages 770-780.
Crossref
Crossref
Francesca Ferrari, Fabio Facchinetti, Alejandra E. Ontiveros, Robyn P. Roberts, Mia M. Saade, Sean C. Blackwell, Baha M. Sibai, Jerrie S. Refuerzo & Monica Longo. (2016) The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. American Journal of Obstetrics and Gynecology 215:4, pages 503.e1-503.e8.
Crossref
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson, Julie Brown & Cindy Farquhar. (2016) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Marco Noventa, Michela Quaranta, Amerigo Vitagliano, Vescio Cinthya, Romina Valentini, Tania Campagnaro, Roberto Marci, Rossana Di Paola, Carlo Alviggi, Michele Gangemi, Carlo Saccardi, Giovanni Battista Nardelli & Salvatore Gizzo. (2016) May Underdiagnosed Nutrition Imbalances Be Responsible for a Portion of So-Called Unexplained Infertility? From Diagnosis to Potential Treatment Options. Reproductive Sciences 23:6, pages 812-822.
Crossref
Crossref
V. Lubin, R. Shojai, P. Darmon & E. Cosson. (2016) A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin. Diabetes & Metabolism 42:3, pages 192-195.
Crossref
Crossref
M. Goeckenjan & C. Reisenb?chler. (2016) Kinderwunschtherapie in der gyn?kologischen PraxisTherapeutic options for infertile patients in gynecology clinics. Gyn?kologische Endokrinologie 14:2, pages 117-130.
Crossref
Crossref
Claudio Celentano, Barbara Matarrelli, Peter A. Mattei, Giulia Pavone, Ester Vitacolonna & Marco Liberati. (2016) Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus. Current Diabetes Reports 16:3.
Crossref
Crossref
Pedro-Antonio Regidor & Adolf Eduard Schindler. (2016) Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Basilio Pintaudi, Giacoma Di Vieste & Matteo Bonomo. (2016) The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Mario Mancini, Alice Andreassi, Michela Salvioni, Fiore Pelliccione, Gianna Mantellassi & Giuseppe Banderali. (2016) Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti & Marialuisa Appetecchia. (2016) Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. International Journal of Endocrinology 2016, pages 1-17.
Crossref
Crossref
Saghar Salehpour, Leila Nazari, Sedighe Hoseini, Nasrin Saharkhiz, Fatemeh Ghazi & Mohammad Reza Sohrabi. (2016) A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Bernd Lesoine & Pedro-Antonio Regidor. (2016) Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Elena Benelli, Scilla Del Ghianda, Caterina Di Cosmo & Massimo Tonacchera. (2016) A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà & Francesco Orio. (2016) Inositols in the Treatment of Insulin-Mediated Diseases. International Journal of Endocrinology 2016, pages 1-6.
Crossref
Crossref
Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas & Fabio Facchinetti. (2016) Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. International Journal of Endocrinology 2016, pages 1-12.
Crossref
Crossref
Mario Montanino Oliva, Elisa Minutolo, Assunta Lippa, Paola Iaconianni & Alberto Vaiarelli. (2016) Effect of Myoinositol and Antioxidants on Sperm Quality in Men with Metabolic Syndrome. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Francesca Caprio, Maria Diletta D’Eufemia, Carlo Trotta, Maria Rosaria Campitiello, Raffaele Ianniello, Daniela Mele & Nicola Colacurci. (2015) Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. Journal of Ovarian Research 8:1.
Crossref
Crossref
Fabio Facchinetti, Mariano Bizzarri, Salvatore Benvenga, Rosario D’Anna, Antonio Lanzone, Christophe Soulage, Gian Carlo Di Renzo, Moshe Hod, Pietro Cavalli, Tony T. Chiu, Zdravko A. Kamenov, Arturo Bevilacqua, Gianfranco Carlomagno, Sandro Gerli, Mario Montanino Oliva & Paul Devroey. (2015) Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. European Journal of Obstetrics & Gynecology and Reproductive Biology 195, pages 72-76.
Crossref
Crossref
Samer Tannus, Yechiel Z Burke & Shahar Kol. (2015) Treatment Strategies for the Infertile Polycystic Ovary Syndrome Patient. Women's Health 11:6, pages 901-912.
Crossref
Crossref
Marine L. Croze, Alain Géloën & Christophe O. Soulage. (2015)
Abnormalities in
myo
-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary
myo
-inositol supplementation
. British Journal of Nutrition 113:12, pages 1862-1875.
Crossref
Crossref
Antonio Simone Laganà & Alfonsa Pizzo. (2015) Authors’ reply to: “Empiric” inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects. Archives of Gynecology and Obstetrics 291:5, pages 959-960.
Crossref
Crossref
Antonio Simone Laganà, Luisa Barbaro & Alfonsa Pizzo. (2014) Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol. Archives of Gynecology and Obstetrics 291:5, pages 1181-1186.
Crossref
Crossref
Mikko Hallman. (2015) Inositol During Perinatal Transition. NeoReviews 16:2, pages e84-e93.
Crossref
Crossref
Francesco Corrado & Angelo Santamaria. 2015. Glucose Intake and Utilization in Pre-Diabetes and Diabetes. Glucose Intake and Utilization in Pre-Diabetes and Diabetes
229
234
.
Minisha Sood, Susan B. Zweig, Marsha C. Tolentino, Marina Strizhevsky & Leonid Poretsky. 2016. Principles of Diabetes Mellitus. Principles of Diabetes Mellitus
1
19
.
Simona Dinicola, Tony T. Y. Chiu, Vittorio Unfer, Gianfranco Carlomagno & Mariano Bizzarri. (2014) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. The Journal of Clinical Pharmacology 54:10, pages 1079-1092.
Crossref
Crossref
Alessandro D. Genazzani, Susanna Santagni, Federica Ricchieri, Annalisa Campedelli, Erika Rattighieri, Elisa Chierchia, Giulia Marini, Giulia Despini, Alessia Prati & Tommaso Simoncini. (2014) Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 40:5, pages 1353-1360.
Crossref
Crossref
Angela Sacchinelli, Roberta Venturella, Daniela Lico, Annalisa Di Cello, Antonella Lucia, Erika Rania, Roberto Cirillo & Fulvio Zullo. (2014) The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. Obstetrics and Gynecology International 2014, pages 1-5.
Crossref
Crossref
Marine L. Croze & Christophe O. Soulage. (2013) Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95:10, pages 1811-1827.
Crossref
Crossref
Marian G Showell, Julie Brown, Jane Clarke & Roger J Hart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Donald R. Coustan. (2013) Can a Dietary Supplement Prevent Gestational Diabetes Mellitus?. Diabetes Care 36:4, pages 777-779.
Crossref
Crossref
. (2013) Clinical Roundup: Selected Treatment Options for Polycystic Ovary Syndrome. Alternative and Complementary Therapies 19:2, pages 101-106.
Crossref
Crossref